WWM
HUMA icon

Wolff Wiese Magana’s Humacyte HUMA Stock Holding History

Wolff Wiese Magana’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391 Hold
500
– – ﹤0.01% 982
2026
Q1 		$304 Hold
500
– – ﹤0.01% 947
2025
Q4 		$481 Hold
500
– – ﹤0.01% 890
2025
Q3 		$870 Hold
500
– – ﹤0.01% 860
2025
Q2 		$1.04K Hold
500
– – ﹤0.01% 837
2025
Q1 		$853 Hold
500
– – ﹤0.01% 872
2024
Q4 		$2.52K Hold
500
– – ﹤0.01% 670
2024
Q3 		$2.72K Hold
500
– – ﹤0.01% 682
2024
Q2 		$2.4K Buy
+500
New +$2.6K ﹤0.01% 516

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wolff Wiese Magana's HUMA Position: Q2 2026 in Review

Wolff Wiese Magana held its Humacyte (HUMA) position steady in Q2 2026 at 500 shares worth $391. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Wolff Wiese Magana first reported a position in HUMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.72K in Q3 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Wolff Wiese Magana held 500 shares of Humacyte worth $391 as of Q2 2026.
  • Wolff Wiese Magana left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #982 holding.
  • Wolff Wiese Magana first reported a position in Humacyte in Q2 2024 and has held it in 9 quarters since.
  • Wolff Wiese Magana's Humacyte position peaked at $2.72K in Q3 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.